- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Codiak BioSciences is a biotechnology & medical research business based in the US. Codiak BioSciences shares (CDAK) are listed on the NASDAQ and all prices are listed in US Dollars. Codiak BioSciences employs 102 staff and has a trailing 12-month revenue of around $34.1 million.
Our top picks for where to buy Codiak BioSciences Inc stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy Codiak BioSciences stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – CDAK. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Codiak BioSciences stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 5 of 5
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Codiak BioSciences stock price (NASDAQ: CDAK)
Use our graph to track the performance of CDAK stocks over time.Codiak BioSciences shares at a glance
Information last updated 2024-06-30.
| 52-week range | $0.00 - $0.00 |
|---|---|
| 50-day moving average | $0.41 |
| 200-day moving average | $1.00 |
| Wall St. target price | $9.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.46 |
Is it a good time to buy Codiak BioSciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Codiak BioSciences financials
| Revenue TTM | $34.1 million |
|---|---|
| Gross profit TTM | $-41,920,000 |
| Return on assets TTM | -22.43% |
| Return on equity TTM | -47.77% |
| Profit margin | -51.13% |
| Book value | $1.06 |
| Market Capitalization | $2.8 million |
TTM: trailing 12 months
Codiak BioSciences share dividends
We're not expecting Codiak BioSciences to pay a dividend over the next 12 months.
You may also wish to consider:
- Amgen (AMGN.US) (3.48% forward annual dividend yield)
Codiak BioSciences share price volatility
Over the last 12 months, Codiak BioSciences's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Codiak BioSciences's is 3.935. This would suggest that Codiak BioSciences's shares are significantly more volatile than the average for this exchange and represent a higher risk.
To put Codiak BioSciences's beta into context you can compare it against those of similar companies.
- Biocept (BIOC.US): 0.595
- BeiGene (BGNE.US): 0.63
- XBiotech (XBIT.US): 1.413
- Amgen (AMGN.US): 0.599
Codiak BioSciences overview
Codiak BioSciences, Inc. , a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of various solid tumors. The company is also developing exoASO-STAT6, an antisense oligonucleotide targeting the STAT6 transcription factor; and exoVACC, a modular platform for constructing precision vaccines. It has a collaboration agreement with the Jazz Pharmaceuticals Ireland Limited, Sarepta Therapeutics, Inc. , Kayla Therapeutics S. A.
Frequently asked questions
nullWhat percentage of Codiak BioSciences is owned by insiders or institutions?
Currently 0.477% of Codiak BioSciences shares are held by insiders and 71.525% by institutions. How many people work for Codiak BioSciences?
Latest data suggests 102 work at Codiak BioSciences. When does the fiscal year end for Codiak BioSciences?
Codiak BioSciences's fiscal year ends in December. Where is Codiak BioSciences based?
Codiak BioSciences's address is: 35 Cambridge Park Drive, Cambridge, MA, United States, 02140 What is Codiak BioSciences's ISIN number?
Codiak BioSciences's international securities identification number is: US1920101060
More resources on Finder
More guides on Finder
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Sweep Accounts
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 Best Day Trading Apps of 2024
These are the best day trading apps, according to Finder’s comprehensive analysis.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
Ratings methodology for online brokers
Our star ratings for online brokerages are based on how they stack up in nine key categories.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to Invest $10K
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question